Hinge Health reported Q1 adjusted EPS of $0.45, topping analysts' $0.12 estimate by $0.33.
Revenue reached $182.3 million, a 47% YoY increase from $123.8 million in Q1 2025.
Company raised FY2026 revenue outlook to $798‑$804 million, midpoint $801 million versus consensus $740.4 million.
Gross margin improved to 85%, adjusted operating income rose 208% to $46.2 million, and free cash flow jumped to $41.6 million.